Pay in 4 interest-free payments of $6.10 Learn more
Ships within 48 hours · Estimated delivery Nov 4 - Nov 9
Clinical eligibility for brand-name GLP-1 medications generally requires an adult patient to have a body mass index (BMI) of 30 or greater, or a BMI of 27 or higher paired with a weight-related health condition such as high blood pressure
Ipamorelin stimulated GH release with similar efficacy to GHRP-6 but did not affect plasma ACTH, cortisol, or prolactin levels at any dose tested
Fix the fundamentals: hydration, protein intake, sleep schedule, daily movement, and stress management
According to the Joi + Blokes site, the medication is administered as a subcutaneous injection into the fatty tissue beneath the skin, with common injection sites including the abdomen, upper arms, and front of the thighs
Listen to the full episode of Lab Notes for more on how GLP-1 agonists work.
